Showing results (271-280 of 2,493) with videos related to

Sort By:
Pageof 250
Antimicrobial Agents and Chemotherapy|December 1, 1979
Miconazole therapy for treatment of fungal infections in cancer patientsW M Jordan, G P Bodey, V Rodriguez, et al.
Annals of Internal Medicine|October 1, 1983
Bacteremia caused by a previously unidentified species of rapidly growing Mycobacterium successfully treated with vancomycinL Jadeja, R Bolivar, R J Wallace, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patientsI Raad, J Narro, A Khan, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patientsK V Rolston, B LeBlanc, G Gooch, et al.
Reviews of Infectious Diseases|May 1, 1985
Bacteremia caused by Aeromonas species in hospitalized cancer patientsR L Harris, V Fainstein, L Elting, et al.
The American Journal of Medicine|November 29, 1985
Ticarcillin plus clavulanic acid in the treatment of patients with cancerV Fainstein, L Elting, S Pitlik, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1985
Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte countsK Rolston, R Bolivar, V Fainstein, et al.
Cancer Treatment Reports|June 1, 1985
Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combinationD F Chiuten, M Valdivieso, A Bedikian, et al.
Infection Control and Hospital Epidemiology|April 1, 1992
Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremiaI Raad, S Davis, A Khan, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolonesN Dholakia, K V Rolston, D H Ho, et al.
Pageof 250